UDHI Acquires Worldwide Rights
for Breakthrough Medical Patent
Mauldin, SC -- September 30,
2020 -- InvestorsHub NewsWire -- Union Dental Holdings,
Inc. 9-30-2020 (OTC:
"UDHI", the "New UDHI") announced signing final Licensing
Agreement with Consulting Group of Jocassee, Inc. ("CGJI"), granting UDHI
world-wide rights to CGJI 's recently awarded Patent,
#10,718,586,as it pertains to design, manufacture, and world-wide
distribution of medical devices. This Agreement also encompasses a
newly filed Patent Application, #17/017,546, that further enhances
previously granted patent, as well
as other intellectual property owned by CGJI pertaining to medical
devices.
Concurrently, UDHI Chief
Science Officer Dr. Anja Glisovic has been preparing a budget and
identifying medical applications that will bring the initial
products to market in the shortest possible time frame. The Company
expects to realize significant revenue from these patented products
throughout FY2021
"I greatly appreciate the
efforts expended by our New UDHI team to expeditiously bring this
Agreement to close" said UDHI CEO Michael
O'Shea. "Special thanks go to my fellow
Director and current President of CGJI, Steve Gravely, who was
instrumental in putting together a well-balanced deal
serving best
interests of all UDHI shareholders."
ABOUT THE NEW
UDHI
On July 2, 2020, forensic
accountant Michael O'Shea accepted the appointment to become the
new CEO and sole Board member of Union Dental Holdings Inc.
("UDHI"), a publicly traded company that had emerged from a FL-727
filing in January 2016 and had been languishing as a public shell
ever since. Mike quickly made two very important additions to the
Board and brought in a highly respected securities attorney to help
him clean up all previous problems associated with the shell and
begin transitioning to a business "worthy of a NASDAQ listing".
That process has now begun in full with the filing of the OTCIQ to
the OTC MARKETS, with the addition of world class Chief Science
Officer, Dr. Anja Glisovic, who is leading the Company's business
development efforts into the medical field, and with the closing of
the Licensing Agreement for the patents discussed above. For more
information on the New UDHI visit NEWUDHI.com
SAFE HARBOR
This press release may contain
forward-looking information within the meaning of Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), including all statements that are not statements of
historical fact regarding intent, belief or current expectations of
the Company, its directors or its officers with respect to, among
other things: (i) the Company's financing
plans; (ii) trends affecting the Company's financial condition or
results of operations; (iii) the Company's growth strategy and
operating strategy; and (iv) the declaration and payment of
dividends. The words "may," "would," "will," "expect," "estimate,"
"anticipate," "believe," "intend," and similar expressions and
variations thereof are intended to identify forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company's
ability to control, and actual results may differ materially from
those projected in the forward-looking statements as a result of
various factors.
Media Contact: Adrienne
Mazzone, amazzone@transmediagroup.com 561-908-1683
CompanyWebsite:
www.newudhi.com